Heart failure in thyrotoxic cardiomopathy: Extracorporeal membrane oxygenation treatment for graves' disease

Joseph Allencherril, Itamar Birnbaum

Research output: Contribution to journalArticlepeer-review

Abstract

Thyrotoxicosis-induced cardiomyopathy and consequent heart failure is one of the most grave complications of uncontrolled hyperthyroidism. In such patients, early recognition of thyrotoxicosis, and directed antithyroid therapy can lead to rapid normalization of left ventricular function. Herein, we present a case of a 29-year-old male with Graves' disease who developed heart failure with severe deterioration of left ventricular function and eventually, circulatory collapse. Height and weight of the patient were 1.8 m and 84 kg, respectively. The patient was placed on venoarterial extracorporeal membrane oxygenation for immediate circulatory support, with restoration of cardiac function after 6 days.

Original languageEnglish (US)
Pages (from-to)231-232
Number of pages2
JournalJournal of Extra-Corporeal Technology
Volume47
Issue number4
StatePublished - 2015
Externally publishedYes

Keywords

  • Cardiomyopathy
  • Extracorporeal membrane oxygenation
  • Heart failure
  • Hyperthyroidism
  • Thyrotoxicosis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health Professions (miscellaneous)
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Heart failure in thyrotoxic cardiomopathy: Extracorporeal membrane oxygenation treatment for graves' disease'. Together they form a unique fingerprint.

Cite this